Question of the Day – Friday June 30, 2017
Question: The co-ingestion of drugs in which class may potentiate the adverse effects of the drug loperamide?
Question of the Day – Thursday June 29, 2017
Question: What is the chemical denoted by the formula N3Na?
Question of the Day – Tuesday June 27, 2017
Question: What are the mechanisms of action of triptan drugs used in the treatment of migraine headaches?
Question of the Day – Monday June 26, 2017
Question: What percentage of drug-induced cases of torsade de pointes are associated with previously unrecognized long QT syndrome?
Question of the Day – Friday June 23, 2017
Question: What is methyl ethyl ketone? By what other name is this chemical known?
Question of the Day – Thursday June 22, 2017
Question: Which anti-arrythmic drug has been associated with a so-called “pancerebellar syndrome” associated with “nystagmus, dysmetria, titubation, and ataxia of gait and stance”?
Question of the Day – Wednesday June 21, 2017
Question: Can buprenorphine be used as an effective modality for the treatment of neonatal abstinence syndrome?
Question of the Day – Tuesday June 20, 2017
Question: Nephrolithiasis is a known complication associated with treatment of HIV using the protease inhibitor indinavir sulfate. What unique factor often makes the diagnosis of nephrolithiasis secondary to Indinavir difficult?
Question of the Day – Monday June 19, 2017
Question: What are the usual clinical manifestations of hyper-magnesemia?